Dxcover vs Thrive Earlier Detection

Dxcover logo

Dxcover

The Future of Cancer Diagnostics

24 employees · est. 2016

VS
Thrive Earlier Detection logo

Thrive Earlier Detection

Pioneering Life-Saving Cancer Detection with Advanced Liquid Biopsy Solutions

est. 2019

Dxcover is the older company (2016 vs 2019).

Side-by-Side Comparison

Dxcover Thrive Earlier Detection
Founded
2016 older 2019
Employees
24 Not tracked yet
Industry
Biotechnology, Health Care, Machine Learning Biotechnology, Health Care
Funding Stage
Series A Venture round
Total Funding
$14.40M $367.00M
Funding Rounds
6 3
Taxonomy
Liquid BiopsyCancer DiagnosticsEarly DetectionInfrared SpectroscopyClinical StageBiomarkers +5 Cancer DetectionLiquid BiopsyEarly Cancer DetectionBiotechInvestmentVenture Capital +2
Website
dxcover.com thrivedetect.com
Dxcover logo

About Dxcover

Dxcover is a clinical stage liquid biopsy company that focuses on the early detection of multiple cancers for more effective treatment outcomes. Using infrared spectroscopy of circulating pan-omic biomarkers, the company has pioneered the early detection and identification of cancer, with compelling...

Thrive Earlier Detection logo

About Thrive Earlier Detection

Thrive Earlier Detection is a healthcare company striving to revolutionize cancer detection through its advanced liquid biopsy solution, CancerSEEK. The company's dedication to integrating earlier cancer detection into routine medical care is reflected in its mission to save lives. Founded in 2019 b...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Dxcover and Thrive Earlier Detection for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Dxcover or Thrive Earlier Detection moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Dxcover was founded in 2016, with 24 employees. Dxcover is a clinical stage liquid biopsy company that focuses on the early detection of multiple cancers for more effective treatment outcomes. Using infrared spectroscopy of circulating pan-omic bio. Thrive Earlier Detection was founded in 2019. Thrive Earlier Detection is a healthcare company striving to revolutionize cancer detection through its advanced liquid biopsy solution, CancerSEEK. The company's dedication to integrating earlier can.
Dxcover has raised $14.40M and Thrive Earlier Detection $367.00M. Latest stage: Dxcover Series A, Thrive Earlier Detection Venture round.
Both work in Biotechnology and Health Care and list liquid biopsy and biotech among their focus areas.

Compare Dxcover with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Dxcover on 12 Sep 2024, and Thrive Earlier Detection on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes